Jeremy Grantham Merck & Co., Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$27.2 Billion
Q1 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 4,727,058 shares of MRK stock, worth $620 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

4,727,058

Previous 4,025,858 17.42%

Holding current value

$620 Million

Previous $439 Million 42.11%

% of portfolio

2.29%

Previous 1.95%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $79.4 Million - $92.5 Million	701,200 Added 17.42%	4,727,058 $624 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $306,350 - $333,383	-3,058 Reduced 0.08%	4,025,858 $439 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $42.3 Million - $47 Million	411,073 Added 11.36%	4,028,916 $415 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $61.3 Million - $66.8 Million	564,296 Added 18.48%	3,617,843 $417 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $9.19 Million - $10.3 Million	-89,264 Reduced 2.84%	3,053,547 $325 Million

Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $3.16 Million - $4.05 Million	36,156 Added 1.16%	3,142,811 $349 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $278,949 - $313,368	-3,300 Reduced 0.11%	3,106,655 $268 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $61.6 Million - $69.8 Million	-737,348 Reduced 19.17%	3,109,955 $284 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $4.41 Million - $4.94 Million	59,929 Added 1.58%	3,847,303 $316 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $5.58 Million - $6.99 Million	77,162 Added 2.08%	3,787,374 $290 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $9.92 Million - $10.9 Million	138,334 Added 3.87%	3,710,212 $279 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $20.5 Million - $22.6 Million	291,195 Added 8.88%	3,571,878 $278 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $17.5 Million - $20.6 Million	254,063 Added 8.39%	3,280,683 $253 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $858,082 - $952,295	11,956 Added 0.4%	3,026,620 $248 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $4.03 Million - $4.57 Million	55,060 Added 1.86%	3,014,664 $250 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $6.16 Million - $7.01 Million	-87,498 Reduced 2.87%	2,959,604 $229 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $50 Million - $69.4 Million	-789,823 Reduced 20.58%	3,047,102 $234 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $5.82 Million - $6.56 Million	-74,970 Reduced 1.92%	3,836,925 $349 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $14.6 Million - $15.9 Million	191,749 Added 5.15%	3,911,895 $329 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $44.6 Million - $52.1 Million	639,128 Added 20.74%	3,720,146 $312 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $32.6 Million - $37.2 Million	-468,524 Reduced 13.2%	3,081,018 $256 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $27.6 Million - $32.1 Million	-423,445 Reduced 10.66%	3,549,542 $271 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $2.28 Million - $2.68 Million	39,511 Added 1.0%	3,972,987 $282 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $58.9 Million - $69.2 Million	1,158,638 Added 41.76%	3,933,476 $239 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $116 Million - $135 Million	2,279,670 Added 460.38%	2,774,838 $151 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $21.7 Million - $25.9 Million	420,368 Added 561.99%	495,168 $27.9 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $4.02 Million - $4.32 Million	68,500 Added 1087.3%	74,800 $4.79 Million
Q2 2017 Aug 14, 2017	BUY	N/A	6,300	6,300 $404,000

Others Institutions Holding MRK

# of Institutions

3,757

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $332B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account